Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Parallel, Randomized, Double‐Blind, Placebo‐Controlled Trial with an Open‐Label Rescue Phase to Evaluate the Efficacy and Safety of Caffeine Citrate for Treatment of Apnea of Prematurity (AOP)

Next Previous
Trial Profile

A Multicenter, Parallel, Randomized, Double‐Blind, Placebo‐Controlled Trial with an Open‐Label Rescue Phase to Evaluate the Efficacy and Safety of Caffeine Citrate for Treatment of Apnea of Prematurity (AOP)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 19 Apr 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 19 Apr 2018 In this study (TGA document), 87 infants were randomized to two groups (46 were randomized to caffeine and 41 to placebo).Two patients did not receive drug and 3 were not included in the efficacy analysis because they had < 6 apnea episodes/24 hours at baseline.I have kept actual patient number as 87.
  • 19 Apr 2018 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top